Literature DB >> 34150435

Retrospective study of factors associated with progression and remission/regression of diabetic kidney disease-hypomagnesemia was associated with progression and elevated serum alanine aminotransferase levels were associated with remission or regression.

Tatsuo Yanagawa1,2, Keiko Koyano2, Koichiro Azuma1.   

Abstract

AIM: This study was aimed at retrospectively investigating some common clinical factors, including the serum level of magnesium (Mg), associated with progression and remission/regression of diabetic kidney disease (DKD).
METHODS: The subjects were 690 Japanese patients with type 2 diabetes mellitus who were receiving treatment with oral antidiabetic drugs other than SGLT2 inhibitors. Routine clinical data were collected on the first and last day of the observation period. The prognosis of DKD is categorized into four stages according to the Kidney Disease Improving Global Outcomes classification. Progression was defined as transition from any of the lower three risk categories (LR, MIR, HR) at the start of the observation period, to the VHR stage/category at the end of the observation period. Remission/regression was defined as improvement of the risk category by at least one stage from the start to the end of the observation period. Factors associated with progression and regression/remission were investigated using Cox proportional hazards analysis. Furthermore, the factors associated with the annual decrease in eGFR of 5 ml/min/1.73 m2 or more were examined by logistic regression analysis. Factors associated with transition of urinary protein negative to trace or positive, or transition of negative or trace to positive, were investigated by Cox proportional hazard analysis.
RESULTS: The observation period was 2251 ± 1614 days. Age (Exp [B] = 1.10, 95% CI; 1.06-1.14; P < 0.01; 1 year old), serum Mg (Exp [B] = 0.82, 95% CI; 0.71-0.95; P < 0.01); 0.1 mg/dl), and serum HbA1c (Exp [B] = 1.03, 95% CI; 1.01-1.05; P < 0.01: 0.1%) were associated with progression of DKD; on the other hand, serum ALT was associated with the likelihood of remission/regression of DKD (Exp [B] = 1.01, 95% CI; 1.002-1.018; P < 0.05; 1 IU/L). The decline in eGFR was associated with higher HbA1c levels, hypomagnesemia, and lower ALT. The new appearance of trace or overt proteinuria was correlated with higher HbA1c levels, advancing age, hypomagnesemia and hypertriglycemia.
CONCLUSION: Our findings confirmed previous reports that advancing age and serum HbA1c levels were associated with an increased risk of progression of DKD. Lower serum Mg concentrations were also found to be associated with a high risk of progression of DKD, and interventional studies are needed to confirm a causal relationship. Elevated HbA1c levels and hypomagnesemia were common factors in the decline in eGFR and the appearance of trace or overt proteinuria. Lower serum ALT levels were associated with the decline in eGFR. Since serum ALT is known to decrease as the renal function deteriorates, serum ALT is considered to be a marker of renal function. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13340-020-00483-1. © The Japan Diabetes Society 2021.

Entities:  

Keywords:  Age factors; Alanine aminotransferase (ALT); Magnesium; Nephropathy; Retrospective study

Year:  2021        PMID: 34150435      PMCID: PMC8172700          DOI: 10.1007/s13340-020-00483-1

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  37 in total

1.  Increasing Number of People with Diabetes in Japan: Is This Trend Real?

Authors:  Atsushi Goto; Mitsuhiko Noda; Manami Inoue; Maki Goto; Hadrien Charvat
Journal:  Intern Med       Date:  2016-07-15       Impact factor: 1.271

2.  The association of low serum alanine aminotransferase activity with mortality in the US population.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Am J Epidemiol       Date:  2013-09-26       Impact factor: 4.897

3.  A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Yoshitsugu Obi; Chikako Monden; Tatsufumi Oka; Satoshi Yamaguchi; Isao Matsui; Nobuhiro Hashimoto; Ayumi Matsumoto; Karin Shimada; Yoshitsugu Takabatake; Atsushi Takahashi; Jun-Ya Kaimori; Toshiki Moriyama; Ryohei Yamamoto; Masaru Horio; Koichi Yamamoto; Ken Sugimoto; Hiromi Rakugi; Yoshitaka Isaka
Journal:  J Am Soc Nephrol       Date:  2019-04-29       Impact factor: 10.121

4.  Diabetic Kidney Disease: Challenges, Progress, and Possibilities.

Authors:  Radica Z Alicic; Michele T Rooney; Katherine R Tuttle
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

5.  Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.

Authors:  Abeba M Berhane; E Jennifer Weil; William C Knowler; Robert G Nelson; Robert L Hanson
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-18       Impact factor: 8.237

Review 6.  Remission and regression of diabetic nephropathy.

Authors:  Peter Hovind; Lise Tarnow; Hans-Henrik Parving
Journal:  Curr Hypertens Rep       Date:  2004-10       Impact factor: 5.369

7.  Magnesium intake decreases Type 2 diabetes risk through the improvement of insulin resistance and inflammation: the Hisayama Study.

Authors:  A Hata; Y Doi; T Ninomiya; N Mukai; Y Hirakawa; J Hata; M Ozawa; K Uchida; T Shirota; T Kitazono; Y Kiyohara
Journal:  Diabet Med       Date:  2013-06-29       Impact factor: 4.359

8.  Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?

Authors:  Hiroki Miyazaki; Akira Babazono; Takumi Nishi; Toshiki Maeda; Takuya Imatoh; Masayoshi Ichiba; Hiroshi Une
Journal:  BMC Pharmacol Toxicol       Date:  2015-09-11       Impact factor: 2.483

Review 9.  Chronic kidney disease and nonalcoholic Fatty liver disease-is there a link?

Authors:  L Orlić; I Mikolasevic; Z Bagic; S Racki; D Stimac; S Milic
Journal:  Gastroenterol Res Pract       Date:  2014-03-06       Impact factor: 2.260

Review 10.  Clinical predictive factors in diabetic kidney disease progression.

Authors:  Nicholas J Radcliffe; Jas-Mine Seah; Michele Clarke; Richard J MacIsaac; George Jerums; Elif I Ekinci
Journal:  J Diabetes Investig       Date:  2016-06-08       Impact factor: 4.232

View more
  2 in total

1.  A systematic review of statistical methodology used to evaluate progression of chronic kidney disease using electronic healthcare records.

Authors:  Faye Cleary; David Prieto-Merino; Dorothea Nitsch
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

2.  Association Between Serum Albumin Level and Microvascular Complications of Type 2 Diabetes Mellitus.

Authors:  Jie Zhang; Yuanyuan Deng; Yang Wan; Shasha He; Wei Cai; Jixiong Xu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-23       Impact factor: 3.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.